FindTrial
Sign In

Substrate Targeted Ablation of Persistent Atrial Fibrillation Trial

Substrate Targeted Ablation of Persistent Atrial Fibrillation Trial - START Trial

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000022119
Enrollment
500
Registered
2016-07-14
Start date
2015-09-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Persistent Atrial Fibrillation Patients

Interventions

Pulmonary vein antrum isolation (PVAI) and Left atrial low voltage zone (LVZ) ablation for patients with LVZ. PVAI only for patients with LVZ. PVAI for patients without LVZ.

Sponsors

EP Expert Doctors-Team Tsuchiya
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Persistent atrial fibrillation patient who is undergoing initial atrial fibrillation ablation.

Exclusion criteria

Exclusion criteria: Patients with low cardiac function, left atrial thrombus, contraindication of anticoagulant therapy.

Design outcomes

Primary

MeasureTime frame
Acute teremination of atrisl fibrillation, long term success, and complications after left atrial low voltage zone ablation.—

Countries

Japan

Contacts

Public ContactFukui Akira

EP Expert Doctors-Team Tsuchiya Electrophysiology

akira18@oita-u.ac.jp090-2513-7156

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026